Use of insulin sensitizers in NASH

被引：11

作者：

Khashab, Mouen ^{[1
]}

Chalasani, Naga ^{[1
]}

机构：

[1] Indiana Univ, Sch Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2007年 / 36卷 / 04期

关键词：

D O I：

10.1016/j.ecl.2007.07.006

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.

引用

页码：1067 / +

页数：22

共 79 条

[1]

The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].

Adams, LA ;

Lymp, JF ;

St Sauver, J ;

Sanderson, SO ;

Lindor, KD ;

Feldstein, A ;

Angulo, P .

GASTROENTEROLOGY, 2005, 129 (01) :113-121

[2]

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies [J].

Adams, LA ;

Sanderson, S ;

Lindor, KD ;

Angulo, P .

JOURNAL OF HEPATOLOGY, 2005, 42 (01) :132-138

[3]

Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction [J].

Adams, LA ;

Feldstein, A ;

Lindor, KD ;

Angulo, P .

HEPATOLOGY, 2004, 39 (04) :909-914

[4]

Al-Salman J, 2000, ANN INTERN MED, V132, P121, DOI 10.7326/0003-4819-132-2-200001180-00006

[5]

Metformin-induced acute hepatitis [J].

Babich, MM ;

Pike, I ;

Shiffman, ML .

AMERICAN JOURNAL OF MEDICINE, 1998, 104 (05) :490-492

[6]

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients [J].

Bajaj, M ;

Suraamornkul, S ;

Piper, P ;

Hardies, LJ ;

Glass, L ;

Cersosimo, E ;

Pratipanawatr, T ;

Miyazaki, Y ;

Defronzo, RA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :200-206

[7]

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis [J].

Barbier, O ;

Torra, IP ;

Duguay, Y ;

Blanquart, C ;

Fruchart, JC ;

Glineur, C ;

Staels, B .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) :717-726

[8]

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].

Belfort, Renata ;

Harrison, Stephen A. ;

Brown, Kenneth ;

Darland, Celia ;

Finch, Joan ;

Hardies, Jean ;

Balas, Bogdan ;

Gastaldelli, Amalia ;

Tio, Fermin ;

Pulcini, Joseph ;

Berria, Rachele ;

Ma, Jennie Z. ;

Dwivedi, Sunil ;

Havranek, Russell ;

Fincke, Chris ;

DeFronzo, Ralph ;

Bannayan, George A. ;

Schenker, Steven ;

Cusi, Kenneth .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307

[9]

Severe cholestatic hepatitis caused by thiazolidinediones: Risks associated with substituting rosiglitazone for troglitazone [J].

Bonkovsky, HL ;

Azar, R ;

Bird, S ;

Szabo, G ;

Banner, B .

DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (07) :1632-1637

[10]

Ethnic differences in the prevalence of cryptogenic cirrhosis [J].

Browning, JD ;

Kumar, KS ;

Saboorian, H ;

Thiele, DL .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (02) :292-298

← 1 2 3 4 5 6 7 8 →